Rhythm Pharmaceuticals (RYTM) P/E (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) P/E from Oct 5, 2017 to Jul 21, 2026. The TTM Rhythm Pharmaceuticals (RYTM) P/E is -35.04. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Rhythm Pharmaceuticals (RYTM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -35.04 | -1.50% |
| 2025 | -35.57 | +170.16% |
| 2024 | -13.17 | -7.30% |
| 2023 | -14.20 | +71.90% |
| 2022 | -8.26 | +14.60% |
| 2021 | -7.21 | -26.37% |
| 2020 | -9.79 | +65.16% |
| 2019 | -5.93 | -49.69% |
| 2018 | -11.79 | -22.62% |
| 2017 | -15.23 | N/A |
Comparison Rhythm Pharmaceuticals (RYTM) P/E with competitors
Rhythm Pharmaceuticals (RYTM) P/E is -35.04.